Ischemic Optic Neuropathy clinical trials at University of California Health
1 in progress, 0 open to eligible people
Showing trials for
NA-AION Risk Factors: New Perspectives
Sorry, not currently recruiting here
The purpose of the study is to use new diagnostic methods (OCT and OCT-A) to shed light on risk factors for the development of NA-AION. The risk factors we are focusing on are comorbidities along with anatomical and vascular characteristics of the optic nerve.
Our lead scientists for Ischemic Optic Neuropathy research studies include Nailyn Rasool.